A5048625134- Ovarian function and disorders
- Reproductive Biology and Fertility
- Uterine Myomas and Treatments
- Gynecological conditions and treatments
- Endometriosis Research and Treatment
- Intestinal and Peritoneal Adhesions
- Assisted Reproductive Technology and Twin Pregnancy
- Hernia repair and management
- Reproductive System and Pregnancy
- Ectopic Pregnancy Diagnosis and Management
- Reproductive Health and Contraception
- Gestational Diabetes Research and Management
- Reproductive Health and Technologies
- Pharmacology and Obesity Treatment
- Hormonal and reproductive studies
- Ovarian cancer diagnosis and treatment
- Minimally Invasive Surgical Techniques
- Sexual Differentiation and Disorders
- Sperm and Testicular Function
- Prenatal Screening and Diagnostics
- Eating Disorders and Behaviors
- Pediatric Urology and Nephrology Studies
- Surgical Sutures and Adhesives
- Ethics in Clinical Research
- Pregnancy-related medical research
Sheffield Teaching Hospitals NHS Foundation Trust
2015-2024
University of Sheffield
2009-2024
Royal Hallamshire Hospital
2009-2024
Jessop Hospital
2007-2023
University of York
2022
Egyptian Information Telecommunications Electronics and Software Alliance
2020
Migration Institute of Australia
2018
Ninewells Hospital
2006-2012
University of Dundee
2011
BACKGROUNDLaparoscopic ovarian diathermy (LOD) is currently accepted as a successful second-line treatment for ovulation induction (OI) in clomiphene citrate (CC)-resistant women with polycystic ovary syndrome (PCOS). The aim of this study was to test the hypothesis that LOD may be superior CC first-line treatment.
Luteal phase support in assisted reproduction cycles BackgroundThe luteal vitro fertilization (IVF) is insufficient and therefore supported with either progesterone, hCG or gonadotrophin-releasing hormone (GnRH) agonists.Luteal improves implantation rates thus pregnancy rates, but the ideal method still unclear.Progesterone most frequently used, known for risk of ovarian hyperstimulation syndrome (OHSS), also widely used.GnRH agonists a new support.This summary meta-analysis published by...
Overweight and obese women have been shown to an increased risk of recurrent miscarriage as well other adverse reproductive outcomes, but it is yet unclear whether this due effect on the endometrium, embryo or both. The current study employs proteomic analysis examine for a potential endometrial defect in overweight with miscarriage. Proteomic tissue 21 samples obtained In midluteal phase from 16 (obese, n = 12 lean, 4) 5 fertile volunteers (Obese, 2 Lean, 3). Proteins were separated using...
Treatment of obesity-related anovulation poses a significant clinical challenge. Occasionally, the use antiobesity medications such as orlistat or insulin sensitizing agents metformin is sometimes indicated in these patients. This study aimed to compare effects and for improving ovulation obese anovulatory women.This was an open-label RCT. A total 40 women were randomized receive either (n = 20) 20). BMI well androgen profile ovulatory status assessed at baseline four weekly intervals 3...